Pan-tumor(NSCLC, gyn cancers, BTC and uc)

Clinical trials for Pan-tumor(NSCLC, gyn cancers, BTC and uc) explained in plain language.

Never miss a new study

Get alerted when new Pan-tumor(NSCLC, gyn cancers, BTC and uc) trials appear

Sign up with your email to follow new studies for Pan-tumor(NSCLC, gyn cancers, BTC and uc), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

HER2 test showdown: which lab method is best for chinese cancer patients?

Knowledge-focused Recruiting now

This study looks at tumor samples from 2,100 Chinese patients with lung, gynecologic, bile duct, or bladder cancers. Researchers will compare different HER2 testing methods to see how well they agree with each other. The goal is to improve the accuracy of HER2 testing, which help…

Matched conditions: PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC)

Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Aug 13, 2026 00:00 UTC

Pan-tumor(NSCLC, gyn cancers, BTC and uc)

Get alerted when new Pan-tumor(NSCLC, gyn cancers, BTC and uc) trials appear

HER2 test showdown: which lab method is best for chinese cancer patients?